Cytovale

Cytovale makes the IntelliSep test, an FDA-cleared in vitro diagnostic that risk-stratifies emergency department patients for sepsis with organ dysfunction by analyzing the biomechanical properties of white blood cells. IntelliSep delivers results in approximately 8 minutes from a small blood sample, enabling faster triage and treatment decisions in a condition where every hour of delay increases mortality by 8%. The test has demonstrated a 42% reduction in mortality and 56% increase in ED discharges in clinical studies.